The deflated Sharpe view tests the best of four trials against the Sharpe ratio that luck alone would reach.
The deflated Sharpe view tests the best of four trials against the Sharpe ratio that luck alone would reach.

Evidence map

AspectFinding
What it isThe Probabilistic Sharpe Ratio evaluated against a benchmark SR₀ that is not zero but the expected maximum Sharpe achievable by chance across N trials — deflating an observed Sharpe for multiple testing, sample length, and non-normality simultaneously.
Key result / formulaDSR = Φ( (SR̂ − SR₀)·√(n−1) / √(1 − γ₃·SR̂ + ((γ₄−1)/4)·SR̂²) ), with the multiple-testing benchmark SR₀ = √V · [ (1−γ)·Z⁻¹(1 − 1/N) + γ·Z⁻¹(1 − 1/(N·e)) ], where V = variance of the trial Sharpe ratios, N = number of trials, γ ≈ 0.5772 (Euler–Mascheroni), Z⁻¹ = inverse normal CDF, SR̂ non-annualized. DSR > 0.95 ⇒ the strategy beats the multiple-testing null with 95% confidence.
Why it matters for backtestingA raw Sharpe is meaningless without N and V.

Why it matters for backtesting

DSR is the practical antidote to backtest overfitting: it shrinks Sharpes discovered after many trials toward the noise floor. Many "1.5 Sharpe" backtests collapse under DSR once N is counted in full — the correct null is "beat SR₀", not "beat zero".

Worked check

A daily Sharpe of 0.10 over 252 independent days has a rough annualized value of 0.10 × sqrt(252) ≈ 1.59. That calculation says nothing about how many alternatives were tried. DSR instead evaluates the observed Sharpe against an expected maximum under a stated effective trial count, with a standard error affected by sample length, skew and kurtosis. Entering one trial after a sweep of 100 configurations understates the selection hurdle. Conversely, treating 100 nearly identical windows as 100 independent trials overstates it. Report the trial population and its dependence estimate. A DSR probability measures evidence conditional on those inputs; it is not a forecast of live returns or a correction for stale data and costs.

Source

Bailey & López de Prado, "The Deflated Sharpe Ratio: Correcting for Selection Bias, Backtest Overfitting, and Non-Normality", Journal of Portfolio Management 40(5), 2014, pp. 94–107 (SSRN 2460551).

Related in the library